Osanni Bio
PrivateLast Round
Series B
Jun 23, 2026
Total Funding Raised
$217M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Osanni Bio operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series B round in June 2026.
Osanni Bio is a biotechnology company that operates a development-stage therapeutics platform to discover and develop new medicines, with programs in ophthalmology, cardiology, and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Osanni Bio Comparables
Compare Osanni Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PureTech Health | 83% | |
| Retromer Therapeutics | 82% | |
| Eli Lilly and Company | 74% |
For institutional investors. Book with your work email.
Osanni Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 23, 2026 | ||||
| Seed | Oct 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Osanni Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horowitz Group | Series A, Seed, Series B |
| Patient Square Capital | Series B |
| Invus Opportunities | Series A, Seed, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2026
Grew 25% QoQ, from 28 to 35 employees.
- Jun 23, 2026
$190M round led by Patient Square Capital
For institutional investors. Book with your work email.
Osanni Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Osanni Bio's valuation, stock price, and market status.
Is Osanni Bio a public or private company?
Osanni Bio is a private company.
What is the current stock price of Osanni Bio?
Osanni Bio is a private company, so its shares have no public market price. Caplight tracks Osanni Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Osanni Bio worth (valuation)?
Valuation information for Osanni Bio is not publicly available.
Can I buy Osanni Bio stock?
Osanni Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Osanni Bio's last funding round?
Osanni Bio's most recent funding round was Series B on June 23, 2026.
Who are the main investors in Osanni Bio?
Key investors in Osanni Bio include Patient Square Capital.
Will Osanni Bio IPO soon?
No public IPO plans have been announced for Osanni Bio.
How can I track Osanni Bio secondary market activity?
Caplight tracks bids, offers, and trades in Osanni Bio's shares on secondary markets.